eScholarship
metadata only
Post-Ischemic Inhibition of the Mitochondrial Ca2+ Uniporter with Ru265 Protects in Ex Vivo and In Vivo Models of Cerebral Ischemia.
Brain ischemia is a leading cause of morbidity and mortality in the aging population, yet no effective neuroprotective interventions currently exist. This therapeutic gap stems from two key challenges: the inability to deliver neuroprotective drugs before reperfusion and limited understanding of pos
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Impact of Vitamin C on Biomarkers of Neurologic Injury in Survivors of Cardiac Arrest#1009290
- Improving Outcomes for Patients With Life-Threatening Neurologic Illness#1112545
- Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers#806642
- Effect of Acetaminophen on Neurological Outcome in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment#1103377
- Rosuvastatin and Ischemia Reperfusion#1057115
Record · ID 1165875
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive